Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine versus gemcitabine + cisplatin for advanced biliary tract cancer
ISRCTN82956140Phase 3Completed
- Sponsor
- University College London
- Start
- Mar 2005
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial in biliary cancer and cholangiocarcinoma (CCA) comparing Gemcitabine with Gemcitabine + cisplatin (2 arms). Primary endpoint: Overall survival. Started Mar 2005; status: completed.
02
Drugs
gemcitabinecisplatin
03
Conditions
biliary cancercholangiocarcinoma (CCA)
Beyond the preview
Go deeper on ISRCTN82956140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN82956140.